Decoding type 5 diabetes using spatial omics: microarchitectural and molecular mechanisms of malnutrition-associated diabetes

• by Anusha Komati, Kiranmai Mandava, Ajay Anand

• June 5, 2026

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

• by Kerri Miller

• March 11, 2026

• 5 min

Utilizing Machine Learning to Identify Risk Factors for Diabetic Microvascular Complications and Develop a Predictive Model with Gradient Boosting Decision Trees

• by Min Xiao, Yuhao Fu, Yan Li, Qian Liu, Xianyi Qiao, Hongjin Zhang, Xingxing Zhu, Jiajia Wang

• April 21, 2026

Suprachoroidal Injection in the Treatment of Diabetic Macular Edema: Mechanisms, Clinical Advances, and Future Perspectives

• by Chen, Menghan , Jiao, Wanzhen , Liu, Tianwei , Zhao, Bojun

• April 16, 2026